A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis

Abstract Introduction Historically, patients with skin of color are underdiagnosed with psoriasis and underrepresented in clinical trials. In this study, we assess the efficacy and safety of risankizumab in patients with moderate-to-severe plaque psoriasis by race and ethnicity in the open label ext...

Повний опис

Бібліографічні деталі

Автори:	Andrew F. Alexis, Melinda Gooderham, Shawn G. Kwatra, Ahmad Amin, Susan Taylor, Ramon Espaillat, Trisha Rettig, Tianshuang Wu, Linyu Shi, Mark I. Kaldas, Deanne M. Dilley, Ranjeeta Sinvhal, Chudy Nduaka, Benjamin Lockshin
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Adis, Springer Healthcare 2024-10-01
Серія:	Dermatology and Therapy
Предмети:	Skin of color Psoriasis Race Ethnicity Efficacy Diversity
Онлайн доступ:	https://doi.org/10.1007/s13555-024-01268-z
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!